No insider purchase over the last 90 days. The latest, by 박은희, was filed 22 Nov 2024.
Who traded when
BuySaleSince the insiders bought
- -16.8%Entry ₩16,400 · Close at T+365 ₩13,640
- -45.5%Entry ₩39,200 · Close at T+365 ₩21,350
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- 0KRXDART:20260528000861
- 0KRXDART:20260515002897
- 0KRXDART:20260403003411
- ●Executives0DART
- ●Executives0DART
- 51,535 sharesKRXDART:20250807000332
- ●Executives0DART
- 100,000 sharesShareKRXDART:20241122000544Canonical exit: 20 Feb 2025 (T+90)
- 0KRXDART:20241122000553
- 100,000 sharesShareKRXDART:20241122000532
- 0KRXDART:20240830002129
- 0KRXDART:20240813001046
- 0KRXDART:20240531002737
- 1,038 sharesKRXDART:20240216001195
- 0KRXDART:20230906000312
- 0KRXDART:20230818000410
- 0KRXDART:20230602000584
- 0KRXDART:20230306000438
- 0KRXDART:20230217001559
- 0KRXDART:20221206000260
- 0KRXDART:20220902000302
- 0KRXDART:20220607000270
- 790 shares@ ₩39,800.00100.0% of flowShareKRXDART:20220405000176Canonical exit: 28 Jun 2022 (T+90)
25 of 56 declarations
About KOREA PHARMA Co., Ltd.
박은희, filed as 대량보유자, appears in 50 of the 54 filings at 한국파마 (KOREA PHARMA Co., Ltd.), a health care name from South Korea worth KRW 90.5 billion. Those filings include 1 purchase and 2 sales; the whole record counts only 2 purchases and 3 sales, or 40% purchases among open-market trades. A further 49 filings are of another kind.
Only one purchase carries an amount: EUR 23,267 for 김진형, on March 30, 2022. 박재돈 filed one sale, and 최판길 and 반재화 each filed one with neither purchase nor sale.
Read moreShow less
The year 2021 is by far the busiest with 28 filings, against 7 in both 2022 and 2024, 5 in 2023, 3 in 2025 and 4 in 2026. Five filings fall in the last twelve months, none of them a purchase or sale. The first filing dates from February 18, 2021 and the last from May 28, 2026, a median of 4 days after the trade. Insiders hold 64.1% of the capital.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
